GLP-1 vs Qsymia: Comparing Two Popular Weight Loss Medications

If you're exploring prescription weight loss options, you've likely come across both GLP-1 medications like semaglutide and Qsymia. Both are FDA-approved for weight management, but they work in completely different ways. Understanding these differences is essential for making an informed decision with your healthcare provider about which option might be right for you.

What Are GLP-1 Medications?

GLP-1 receptor agonists are a class of medications that mimic a natural hormone your body produces called glucagon-like peptide-1. This hormone plays a key role in regulating appetite and blood sugar levels.

Common GLP-1 medications include semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro). These medications work by slowing digestion, reducing appetite, and helping you feel fuller longer after eating.

Originally developed for type 2 diabetes management, GLP-1 medications have shown remarkable effectiveness for weight loss in clinical trials, leading to FDA approval specifically for obesity treatment.

What Is Qsymia?

Qsymia is a combination medication that contains two active ingredients: phentermine and topiramate extended-release. Phentermine is an appetite suppressant that's been used for decades, while topiramate is an anticonvulsant that also reduces appetite and increases feelings of fullness.

This medication works primarily on your central nervous system to decrease hunger signals and help you eat less. It's been FDA-approved for chronic weight management since 2012.

Qsymia comes in different dose strengths, allowing your doctor to start low and gradually increase based on your response and tolerance.

How They Work: The Key Differences

Mechanism of Action

The fundamental difference lies in how these medications affect your body. GLP-1 medications work by mimicking natural hormones that regulate multiple systems including digestion, appetite signals, and blood sugar control. They create a more physiological approach to weight loss.

Qsymia, on the other hand, uses two medications that directly suppress appetite through your central nervous system. It's a more traditional stimulant-based approach combined with a seizure medication that happens to affect weight.

Administration Methods

GLP-1 medications are injected subcutaneously, typically once weekly for semaglutide or once weekly for tirzepatide. The injection uses a small needle similar to insulin pens, and most people find it manageable after the first few times.

Qsymia is taken orally as a capsule once daily in the morning. For many people, the convenience of a daily pill is appealing compared to weekly injections.

Effectiveness and Weight Loss Results

Clinical trials show different weight loss outcomes for each medication. GLP-1 medications have demonstrated significant weight loss results, with semaglutide showing average weight loss of 15-20% of body weight in clinical studies, and tirzepatide showing even higher results of up to 20-25% in some trials.

Qsymia has shown average weight loss of approximately 10-12% of body weight in clinical studies. While this is less than GLP-1 medications, it's still considered clinically significant weight loss.

It's important to remember that individual results vary widely. Your response to any weight loss medication depends on multiple factors including diet, exercise, genetics, and adherence to treatment.

Side Effects to Consider

GLP-1 Side Effects

The most common side effects of GLP-1 medications are gastrointestinal and include nausea, vomiting, diarrhea, and constipation. These effects are typically most noticeable when starting the medication or increasing doses, and often improve over time.

Other potential effects include fatigue, headache, and in rare cases, more serious concerns like pancreatitis or gallbladder issues. Your doctor will monitor you for these conditions.

Qsymia Side Effects

Because Qsymia contains a stimulant, common side effects include increased heart rate, tingling in hands and feet, dry mouth, constipation, and sleep problems. Some people also experience taste changes, particularly with carbonated beverages.

Qsymia carries important warnings including risk of birth defects, so it requires enrollment in a special program if you're of childbearing potential. It can also increase heart rate and has potential for misuse due to the phentermine component.

Gender-Specific Considerations

For women, Qsymia requires special attention due to potential birth defects. Women of childbearing age must use effective contraception and take monthly pregnancy tests while on this medication. This makes it a more complex choice for younger women.

GLP-1 medications don't have the same birth defect risks, though they're still not recommended during pregnancy. Both medications should be discontinued if you're planning to become pregnant.

Men generally tolerate both medications well, though the stimulant effects of Qsymia may be more noticeable for those with underlying heart conditions or high blood pressure.

Cost and Accessibility

Cost varies significantly between these options. Brand-name GLP-1 medications can be expensive without insurance, though compounded versions are available at more accessible price points through telehealth providers.

Qsymia is also expensive without insurance coverage, and unlike GLP-1 medications, there aren't currently compounded alternatives widely available.

Insurance coverage depends on your specific plan, medical necessity, and whether you have diabetes or other qualifying conditions. Many plans are still developing their coverage policies for weight loss medications.

Which One Might Be Right for You?

The choice between GLP-1 medications and Qsymia depends on multiple personal factors. GLP-1 medications may be preferred if you also have type 2 diabetes, prediabetes, or cardiovascular risk factors, as they provide additional metabolic benefits beyond weight loss.

Qsymia might be considered if you prefer oral medication over injections, or if you've had contraindications to GLP-1 therapy. However, the birth defect risks make it less suitable for women who might become pregnant.

Your medical history matters significantly. If you have a history of eating disorders, heart conditions, glaucoma, or seizures, these factors will influence which medication is safer for you.

Ultimately, this decision should be made collaboratively with your healthcare provider who knows your complete medical picture and can help weigh the benefits and risks specific to your situation.

From the Ozari Care Team

We often see patients concerned about choosing between medication options, but remember that the best weight loss medication is the one you can take consistently and safely. GLP-1 medications offer a more comprehensive metabolic approach with strong evidence for cardiovascular benefits, making them our preferred first-line therapy for most patients seeking medical weight loss support.

Take the Next Step in Your Weight Loss Journey

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026